6
Views
19
CrossRef citations to date
0
Altmetric
Original Article

Nizatidine as Maintenance Therapy of Duodenal Ulcer Disease in Remission

, , , &
Pages 79-83 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

E. Lerebours, P. Michel, P. Hochain & I. Berkelmans. (1994) Nizatidine as Maintenance Treatment of Duodenal Ulcer Clinical Results. Scandinavian Journal of Gastroenterology 29:sup206, pages 52-55.
Read now
P. Rampal, C. Martin, P. Marquis, J. E. Ware & S. Bonfils. (1994) A Quality of Life Study in Five Hundred and Eighty-one Duodenal Ulcer Patients Maintenance versus Intermittent Treatment with Nizatidine. Scandinavian Journal of Gastroenterology 29:sup206, pages 44-51.
Read now
M. L. Cloud & W. Offen. (1994) Continuous Infusions of Nizatidine Are Safe and Effective in the Treatment of Intensive Care Unit Patients at Risk for Stress Gastritis. Scandinavian Journal of Gastroenterology 29:sup206, pages 29-34.
Read now
Greg Gilbert, Chao H. Chan & Eapen Thomas. (1991) Peptic ulcer disease. Postgraduate Medicine 89:4, pages 91-98.
Read now
K. Sumii, A. Inbe, N. Uemura, M. Kimura, K. Haruma, M. Yoshihara, H. Teshima, G. Kajiyama & A. Miyoshi. (1989) Increased Serum Pepsinogen I and Recurrence of Duodenal Ulcer. Scandinavian Journal of Gastroenterology 24:10, pages 1200-1204.
Read now
P. G. Farup, A. R. Rosseland, L. Halvorsen, O. K. Andersen & T. Bernklev. (1989) Duodenal Ulcer Treated with Omeprazole: Healing and Relapse Rates. Scandinavian Journal of Gastroenterology 24:9, pages 1107-1112.
Read now

Articles from other publishers (13)

D. W. PIPER & D. STIEL. (2008) Nizatidine and acid‐pepsin related gastrointestinal disease. Journal of Gastroenterology and Hepatology 10:2, pages 205-207.
Crossref
G. DOBRILLA, L. ZANCANELLA & S. AMPLATZ. (2007) The need for long-term treatment of peptic ulcer. Alimentary Pharmacology & Therapeutics 7, pages 3-15.
Crossref
Serge Bonfils, Patrick Rampal & Vincent About. (1993) La dimension phychologique dans les traitements au long cours Le modèle Nizaxid pour l’ulcère duodénal. Acta Endoscopica 23:2, pages XXIV-XXVII.
Crossref
F. von Bruchhausen, S. Ebel, E. Hackenthal, G. Dannhardt, A. W. Frahm, U. Holzgrabe, K. Keller, E. Nürnberg, H. Rimpler, G. Schneider, P. Surmann, H. U. Wolf & G. Wurm. 1993. Hagers Handbuch der Pharmazeutischen Praxis. Hagers Handbuch der Pharmazeutischen Praxis 1057 1220 .
J. G. PENSTON & K. G. WORMSLEY. (2007) Review article: maintenance treatment with H 2 ‐receptor antagonists for peptic ulcer disease . Alimentary Pharmacology & Therapeutics 6:1, pages 3-29.
Crossref
David L. Earnest. (1991) Maintenance Therapy in Peptic Ulcer Disease. Medical Clinics of North America 75:4, pages 1013-1038.
Crossref
J. H. LEWIS. (2007) Safety profile of long-term H2-antagonist therapy. Alimentary Pharmacology & Therapeutics 5, pages 49-57.
Crossref
John A. Oates, Alastair J.J. Wood, Mark Feldman & Michael E. Burton. (1990) Histamine 2 -Receptor Antagonists . New England Journal of Medicine 323:25, pages 1749-1755.
Crossref
R. H. PALMER, W. O. FRANK & R. KARLSTADT. (2007) Maintenance therapy of duodenal ulcer with H 2 ‐receptor antagonists—a meta‐analysis . Alimentary Pharmacology & Therapeutics 4:3, pages 283-294.
Crossref
R. F. P. QUIK, M. J. COOPER, M. GLEESON, E. HENTSCHEL, K. SCHUETZE, R. D. KINGSTON & M. MITCHELL. (2007) A comparison of two doses of nizatidine versus placebo in the treatment of reflux oesophagitis. Alimentary Pharmacology & Therapeutics 4:2, pages 201-211.
Crossref
James W. Freston. (1990) Overview of Medical Therapy of Peptic Ulcer Disease. Gastroenterology Clinics of North America 19:1, pages 121-140.
Crossref
Rudolf Arnold, Hanns-Gerd Dammann, Peter Minartz, Hans-Dieter Peters & Bernd Simon. 1989. Nizatidin. Nizatidin 83 92 .
Roy Pounder. (1988) Histamine H2-receptor antagonists. Baillière's Clinical Gastroenterology 2:3, pages 593-608.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.